Phosphorylation of tau, aβ-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A

Neurobiology of Aging

Volumn 19, Issue 1, 1998, Pages 3-13

  Arendt, T ^a   Holzer, M ^a   Fruth, R ^a   Bruckner M K ^a   Gartner U ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b NONE

Author keywords

A ; Alzheimer's disease; Amyloid precursor protein; Animal model; Apoptosis; Neuritic plaques; Neurofibrillary degeneration; Okadaic acid; Paired helical filaments; Protein phosphatases; Tau

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; NEUROFILAMENT PROTEIN; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; TAU PROTEIN; ENZYME INHIBITOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME INHIBITION; LATERAL BRAIN VENTRICLE; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; NONHUMAN; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DEGENERATIVE DISEASE; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING; WISTAR RAT;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL DEATH; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; NEURODEGENERATIVE DISEASES; NEUROFILAMENT PROTEINS; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; RATS; RATS, WISTAR; TAU PROTEINS;

EID: 0031596660     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(98)00003-7     Document Type: Article

References (77)

1. Amaratunga A., Fine R. E. Generation of amyloidogenic C-terminal fragments during rapid axonal-transport in-vivo of beta-amyloid precursor protein in the optic-nerve. J. Biol. Chem. 270:1995;17268-17272.
2. Arendt T. Neuronal dedifferentiation and degeneration in Alzheimer's disease. Biol. Chem. Hoppe-Seyler. 374:1993;911-912.
3. Arendt T., Hanisch F., Holzer M., Brückner M. K. In vivo phosphorylation in the rat basal nucleus induces PHF-like and APP immunoreactivity. NeuroReport. 5:1994;1397-1400.
4. Arendt T., Holzer M., Fruth R., Brückner M. K., Gärtner U. Paired helical filament-like phosphorylation of tau, deposition of β/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A. Neurosci. 69:1995;691-698.
5. Arias C., Sharma N., Davies P., Shafitzagardo B. Okadaic acid induces early changes in microtubule-associated protein-2 and tau-phosphorylation prior to neurodegeneration in cultured cortical-neurons. J. Neurochem. 61:1993;673-682.
6. Baum L., Seger R., Woodgett J. R., Kawabata S., Maruyama K., Koyama M., Silver J., Saitoh T. Overexpressed tau-protein in cultured-cells is phosphorylated without formation of Phf - Implication of phosphoprotein phosphatase involvement. Mol. Brain Res. 34:1995;1-17.
7. Bialojan C., Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem. J. 256:1998;283-290.
8. Boe R., Gjertsen B. T., Vintermyr O. K., Houge G., Lanotte M., Doskeland S. O. The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp. Cell Res. 195:1991;237-246.
9. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
10. Bramblett G. T., Goedert M., Jakes R., Merrick S. E., Trojanowski J. Q., Lee V. M.-Y. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contribtes to reduced microtubule binding. Neuron. 10:1993;1089-1099.
11. Cagnoli C. M., Kharlamov E., Atabay C., Uz T., Manev H. Apoptosis induced in neuronal cultures by either the phosphatase inhibitor okadaic acid or the kinase inhibitor staurosporine is attenuated by isoquinolinesulfonamides H-7, H-8, and H-9. J. Mol. Neurosci. 7:1996;65-76.
12. Chajry N., Martin P. M., Cochet C., Berthois Y. Regulation of p42 mitogen-activated-protein kinase activity by protein phosphatase 2A under conditions of growth inhibition by epidermal growth factor in A431 cells. Eur. J. Biochem. 235:1996;97-102.
13. Drewes G., Lichtenberg-Kraag B., Doring F., Mandelkow E. M., Biernat J., Goris J., Doree M., Mandelkow E. Mitogen activated protein (Map) kinase transforms tau-protein into an Alzheimer-like state. EMBO J. 11:1992;2131-2138.
14. Drewes G., Mandelkow E. M., Baumann K., Goris J., Merlevede W., Mandelkow E. Dephosphorylation of tau-protein and Alzheimer paired helical filaments by calcineurin and phosphatase-2A. Fedn. Eur. Biochem. Soc. Lett. 336:1993;425-432.
15. Furiya Y., Sahara N., Mori H. Okadaic acid enhances abnormal phosphorylation on tau proteins. Neurosci. Lett. 156:1993;67-69.
16. Garver T. D., Harris K. A., Lehman R. A. W., Lee V. M. Y., Trojanowski J. Q., Billingsley M. L. Tau-phosphorylation in human, primate, and rat-brain - Evidence that a pool of tau Is highly phosphorylated in-vivo and is rapidly dephosphorylated in-vitro. J. Neurochem. 63:1994;2279-2287.
17. Garver T. D., Lehman R. A. W., Billingsley M. L. Microtubule assembly competence analysis of freshly-biopsied human-tau, dephosphorylated-tau, and Alzheimer tau. J. Neurosci. Res. 44:1996;12-20.
18. Gianfagna T. J., Lawton M. A. Specific activation of soybean defense genes by the phosphoprotein phosphatase inhibitor okadaic acid. Plant Sci. 109:1995;165-170.
19. Giasson B. I., Cromlish J. A., Athlan E. S., Mushynski W. E. Activation of cyclic AMP-dependent protein kinase in okadaic acid-treated neurons potentiates neurofilament fragmentation and stimulates phosphorylation of Ser2 in the low-molecular-mass neurofilament subunit. J. Neurochem. 66:1996;1207-1213.
20. Goedert M., Cohen E. S., Jakes R., Cohen P. P42 map kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase-2A1 - Implications for Alzheimers-disease. Fedn. Eur. Biochem. Soc. Lett. 312:1992;95-99.
21. Goedert M., Jakes R., Vanmechelen E. Monoclonal antibody AT8 recognizes tau protein phosphorylated at both serine-202 and threonine-205. Neurosci. Lett. 189:1995;167-170.
22. Goedert M., Spillantini M. G., Cairns N. J., Crowther R. A. Tau proteins from Alzheimer paired helical filaments abnormal phosphorylation of all six isoforms . Neuron. 8:1992;159-168.
23. Gong C.-X., Grundke-Iqbal I., Damuni Z., Iqbal K. Dephosphorylation of microtubule-associated protein-tau by protein phosphatase-1 and phosphatase-2C and its implication in Alzheimer disease. Fedn. Eur. Biochem. Soc. Lett. 341:1994;94-98.
24. Gong C.-X., Grundke-Iqbal I., Iqbal K. Dephosphorylation of Alzheimers disease abnormally phosphorylated tau by protein phosphatase-2A. Neurosci. 61:1994;765-772.
25. Gong C.-X., Shaikh S., Wang J. Z., Zaidi T., Grundke-Iqbal I., Iqbal K. Phosphatase-activity toward abnormally phosphorylated tau decrease in Alzheimer disease brain. J. Neurochem. 65:1995;732-738.
26. Gong C.-X., Singh T. J., Grundke-Iqbal I., Iqbal K. Phosphoprotein-phosphatase-activities in Alzheimer's disease brain. J. Neurochem. 61:1993;921-927.
27. Gong C.-X., Singh T. J., Grundke-Iqbal I., Iqbal K. Alzheimers-disease abnormally phosphorylated-tau Is dephosphorylated by protein phosphatase-2B (calcineurin). J. Neurochem. 62:1994;803-806.
28. Guan Z. H., Tetsuka T., Baier L. D., Morrison A. R. Interleukin-1 (IL-1)b activates c-jun NH2-terminal kinase subgroup of mitogen-activated protein kinases in mesangial cells. Am. J. Physiol. Renal, Fluid Electrolyte Physiol. 270:1996;F634-F641.
29. Haldar S., Jena N., Croce C. M. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA. 92:1995;4507-4511.
30. Hall G. F., Kosik K. S. Axotomy-induced neurofilament phosphorylation is inhibited in situ by microinjection of pKa and PKC inhibitors into identified Lamprey neurons. Neuron. 10:1993;613-625.
31. Heider H., Widmer H. R. Okadaic acid potentiates heat-induced activation of erk2. Biochim. Biophys. Acta. 1265:1995;196-200.
32. Ichihara N., Wu J., Chui D. H., Yamazaki K., Wakabayashi T., Kikuchi T. Axonal degeneration promotes abnormal accumulation of amyloid beta-protein in ascending gracile tract of gracile axonal dystrophy (GAD) mouse. Brain Res. 695:1995;173-178.
33. Iqbal K., Grundke-Iqbal I., Zaidi T., Merz P. A., Wen G. Y., Shaikh S. S., Wisniewski H. M., Alafuzoff I., Winblad B. Defective brain microtubule assembly in Alzheimer's disease. Lancet. 2:1986;421-426.
34. Ishiguro K., Takamatsu M., Tomizawa K., Omori A., Takahashi M., Arioka M., Uchida T., Imahori K. Tau protein kinase-I converts normal tau protein into A68-like component of paired helical filaments. J. Biol. Chem. 267:1992;10897-10901.
35. Jayaraman D., Giasson B. I., Mushynski W. E. Increased phosphorylation of neurofilament subunits in PC12 cells and rat dorsal-root ganglion neurons treated with N-acetyl-leu-leu-norleucinal. Int. J. Dev. Neurosci. 13:1995;753-758.
36. Kalaria R. N., Bhatti S. U., Palatinsky E. A., Pennington D. H., Shelton E. R., Chan H. W., Perry G., Lust W. D. Accumulation of the beta-amyloid precursor protein at sites of ischemic-injury in rat-brain. NeuroReport. 4:1993;211-214.
37. Kaneko S., Shima H., Amagasa T., Takagi M., Sugimura T., Nagao M. Analysis by in vitro mutagenesis of PP2A alpha okadaic acid responsive sequences. Biochem. Biophys. Res. Commun. 214:1995;518-523.
38. Kawamura K. I., Grabowski D., Weizer K., Bukowski R., Ganapathi R. Modulation of vinblastine cytotoxicity by dilantin (phenytoin) or the protein phosphatase inhibitor okadaic acid involves the potentiation of anti-mitotic effects and induction of apoptosis in human tumour cells. Br. J. Cancer. 73:1996;183-188.
39. Klafki H. W., Wiltfang J., Staufenbiel M. Electrophoretic separation of beta A4 peptides (1-40 and (1-42). Anal. Biochem. 237:1996;24-29.
40. Köpke E., Tung Y. C., Shaikh S., Alonso A. D., Iqbal K., Grundke-Iqbal I. Microtubule-associated protein tau - abnormal phosphorylation of a non-paired helical filament pool in Alzheimer's disease. J. Biol. Chem. 268:1993;24374-24384.
41. Kovoor A., Henry D. J., Chavkin C. Agonist-induced desensitization of the mu-opioid receptor-coupled potassium channel (Girk1). J. Biol. Chem. 270:1995;589-595.
42. Ledesma M. D., Correas I., Avila J., Diaznido J. Implication of brain Cdc2 and Map2 kinases in the phosphorylation of tau protein in Alzheimers-disease. Fedn. Eur. Biochem. Soc. Lett. 308:1992;218-224.
43. Lindwall G., Cole R. D. Phosphorylation affects the ability of tau protein to promote microtubule assembly. J. Biol. Chem. 259:1984;5301-5305.
44. McKee A. C., Kowall N. W., Kosik K. S. Microtubular reorganization and dendritic growth response in Alzheimer's disease. Ann. Neurol. 26:1989;652-659.
45. Maier G. D., Wright M. A., Lozano Y., Djordjevic A., Matthews J. P., Young M. R. I. Regulation of cytoskeletal organization in tumor cells by protein phosphatases-1 and -2A. Int. J. Cancer. 61:1995;54-61.
46. Mandelkow E. M., Drewes G., Biernat J., Gustke N., Vanlint J., Vandenheede J. R., Mandelkow E. Glycogen-synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. Fedn. Eur. Biochem. Soc. Lett. 314:1992;315-321.
47. Matsuo E. S., Shin R. W., Billingsley M. L., Vandevoorde A., Oconnor M., Trojanowski J. Q., Lee V. M. Y. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filment tau. Neuron. 13:1994;989-1002.
48. Miyasaka T., Chao M. V., Sherline P., Saltiel A. R. Nerve growth factor stimulates a protein kinase in PC-12 cells that phosphorylates microtubule-associated protein 2. J. Biol. Chem. 265:1990;4730-4735.
49. Mogi M., Guroff G. Okadaic acid stimulates the activity of the nerve growth factor-sensitive S6 kinase of PC12 cells. Biochem. Biophys. Res. Commun. 177:1991;624-629.
50. Morin P. J., Abraham C. R., Amaratunga A., Johnson R. J., Huber G., Sandell J. H., Fine R. E. Amyloid precursor protein is synthesized by retinal ganglion-cells, rapidly transported to the optic-nerve plasma-membrane and nerve-terminals, and metabolized. J. Neurochem. 61:1993;54-473.
51. Namboodiripad A. N., Jennings M. L. Permeability characteristics of erythrocyte membrane to okadaic acid and calyculin A. Am. J. Physiol Cell Physiol. 270:1996;C449-C456.
52. Otsuka N., Tomonaga M., Ikeda K. Rapid appearance of beta-amyloid precursor protein immunoreactivity in damaged axons and reactive glial- cells in rat-brain following needle stab injury. Brain Res. 568:1991;1-2.
53. Quintaje S. B., Church D. J., Rebsamen M., Valloton M. B., Hemmings B. A., Lang U. Role of protein phosphatase 2A in the regulation of mitogen-activated protein kinase activity in ventricular cardiomyocytes. Biochem. Biophys. Res. Commun. 221:1996;539-547.
54. Sacher M. G., Athlan E. S., Mushynski W. E. Okadaic acid induces the rapid and reversible disruption of the neurofilament network in rat dorsal-root ganglion neurons. Biochem. Biophys. Res. Commun. 186:1992;524-530.
55. Sacher M. G., Athlan E. S., Mushynski W. E. Increased phosphorylation of the amino-terminal domain of the low -molecular-weight neurofilament subunit in okadaic acid-treated neurons. J. Biol. Chem. 269:1994;18480-18484.
56. Saito T., Ishiguro K., Uchida T., Miyamoto E., Kishimoto T., Hisanaga S. In-situ dephosphorylation of tau by protein phosphatase-2A and phosphatase-2B in fetal-rat primary cultured neurons. Fedn. Eur. Biochem. Soc. Lett. 376:1995;238-242.
57. Saito T., Shima H., Osawa Y., Nagao M., Hemmings B. A., Kishimoto T., Hisanaga S. Neurofilament-associated protein phosphatase 2A - Its possible role in preserving neurofilaments in filamentous states. Biochemistry. 34:1995;7376-7384.
58. Sambrock, J.; Fritsch, E. F.; Maniatis T. Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press; Cold Spring Harbor, N.Y.; 2nd edition, 1989.
59. Shea T. B., Fischer I. Phosphatase inhibition in human neuroblastoma-cells alters tau antigenicity and renders it incompetent to associate with exogenous microtubules. Fedn. Eur. Biochem. Soc. Lett. 380:1996;63-67.
60. Shea T. B., Paskevich P. A., Beermann M. L. The protein phosphatase inhibitor okadaic acid increases axonal neurofilaments and neurite caliber, and decreases axonal microtubules in Nb2A/day1 cells. J. Neurosci. Res. 35:1993;507-521.
61. Simons M., Ikonen E., Tienari P. J., Cidarregui A., Mönning U., Beyreuther K., Dotti C. G. Intracellular routing of human amyloid protein-precursor-axonal delivery followed by transport to the dendrites. J. Neurosci. Res. 41:1995;121-128.
62. Slunt H. H., Thinakaran G., Von Koch C., Lo A. C., Tanzi R. E., Sisodia S. S. Expression of a ubiquitous, cross-reactive homolog of the mouse β-amyloid precursor protein (APP). J. Biol. Chem. 269:1994;2637-2644.
63. Sola C., Garcia-Ladona F. J., Mengod G., Probst A., Frey P., Palacios J. M. Increased levels of the Kunitz protease inhibitor-containing beta-App messenger-RNAs in rat-brain following neurotoxic damage. Mol. Brain Res. 17:1993;41-52.
64. Su J. H., Cummings B. J., Cotman C. W. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. NeuroReport. 5:1994;2358-2362.
65. Takai A., Sasaki K., Nagai H., Mieskes G., Isobe M., Isono K., Yasumoto T. Inhibition of specific binding of okadaic acid to protein phosphatase 2A by microcystin-LR, calyculin-A and tautomycin Method of analysis of interactions of tight-binding ligands with target protein . Biochem. J. 306:1995;657-665.
66. Tokuda T., Kametani F., Tanaka K., Sahara N., Ikeda S., Yanagisawa N. Amyloid-beta protein and its 3-kDa fragment are present in the axoplasm fraction of the white-matter in human brain. Biochem. Biophys. Res. Commun. 223:1996;165-169.
67. Vandermeeren M., Lubke U., Six J., Cras P. The phosphatase inhibitor okadaic acid induces a phosphorylated paired helical filament tau-Epitope in human La-N-5 neuroblastoma-cells. Neurosci. Lett. 153:1993;57-60.
68. Veeranna Shetty K. T., Link W. T., Jaffe H., Wang J., Pant H. C. Neuronal cyclin-dependent kinase-5 phosphorylation sites in neurofilament protein (NF-H) are dephosphorylated by protein phosphatase 2A. J. Neurochem. 64:1995;2681-2690.
69. Vincent I., Rosado M., Kim E., Davies P. Increased production of paired helical filament epitopes in a cell-culture system reduces the turnover of tau. J. Neurochem. 62:1994;715-723.
70. Vulliet R., Halloran S. M., Braun R. K., Smith A. J., Lee G. Proline-directed phosphorylation of human tau-protein. J. Biol. Chem. 267:1992;22570-22574.
71. Wang J. Z., Gong C. X., Zaidi T., Grundke-Iqbal I., Iqbal K. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and phosphatase-2B. J. Biol. Chem. 270:1995;4854-4860.
72. Wang J. Z., Grundke-Iqbal I., Iqbal K. Restoration of biological-activity of Alzheimer abnormally phosphorylated-tau by dephosphorylation with protein phosphatase-2A, phosphatase-2B and phosphatase-1. Mol. Brain Res. 38:1996;200-208.
73. Wiltfang J. A., Smirnov A., Schnierstein B., Kelemen G., Matthies U., Klafki H. W., Staufenbiel M., Hüther G., Rüther E., Kornhuber J. Improved electrophoretic separation and immunoblotting of β-amyloid (Aβ) peptides 1-40, 1-42, and 1-43. Electrophoresis. 18:1997;527-532.
74. Yamazaki T., Selkoe D. J., Koo E. H. Trafficking of cell-surface beta-amyloid precursor protein - Retrograde and transcytotic transport in cultured neurons. J. Cell. Biol. 129:1995;431-442.
75. Yang S. D., Chang H. C., Lee S. C. Okadaic acid, sphingosine, and phorbol ester reversibly modulate heat induction on protein kinase FA/GSK-3a in A431 cells. J. Cell. Biochem. 60:1996;218-225.
76. Zhang L. F., Zhang Z. J., Long F. X., Lee E. Y. C. Tyrosine-272 is involved in the inhibition of protein phosphatase-1 by multiple toxins. Biochemistry. 35:1996;1606-1611.
77. Zhang Z., Zhao S., Long F., Zhang L., Bai G., Shima H., Nagao M., Lee E. Y. C. A mutant of protein phosphatase-1 that exhibits altered toxin sensitivity. J. Biol. Chem. 269:1994;16997-17000.